Photo from Matt Wilson/X
Aug 12, 2024, 13:10
Matt Wilson: Updated good practice paper on CNS prophylaxis in LBCL
Matt Wilson, Consultant Haematomogist specialising in lymphoma at The Beatson West of Scotland Cancer Centre, shared on X:
“Just published in British Journal of Haematology – an updated BSH – Haematology good practice paper on the ever-controversial topic of CNS prophylaxis in LBCL!
Pleasure to work with Kate Cwynarski, Toby Eyre, Jeff Smith, Sridhar Chaganti, Chris Fox and Pam McKay on this.
Brief summary:
- Increased emphasis on baseline screening
- ‘Offer’ HD-MTX +/or IT to patients with testicular LBCL
- ‘Consider’ HD-MTX in other high-risk patients (but omission entirely may be acceptable after risk/benefit discussion)
- Use max. 2x HD-MTX at end of systemic treatment”
Source: Matt Wilson/X
Authors: Matthew R. Wilson, Kate Cwynarski, Toby A. Eyre, Jeffery Smith, Sridhar Chaganti, Christopher P. Fox, Pamela McKay
British Journal of Haematology
BSH - Haematology
cancer
central nervous system
Chris Fox
Christopher P. Fox
Jeff Smith
Jeffery Smith
Kate Cwynarski
LBCL
lymphoma
Matt Wilson
Matthew R. Wilson
OncoDaily
Oncology
Pam McKay
Pamela McKay
Sridhar Chaganti
The Beatson West of Scotland Cancer Centre
Toby A. Eyre
Toby Eyre
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46